Cholinergic modulation of the hippocampal region and memory function

J Haam, JL Yakel - Journal of neurochemistry, 2017 - Wiley Online Library
Acetylcholine (AC h) plays an important role in memory function and has been implicated in
aging‐related dementia, in which the impairment of hippocampus‐dependent learning …

[HTML][HTML] A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease

A Nordberg, C Ballard, R Bullock… - The primary care …, 2013 - psychiatrist.com
Objective: To examine the role of butyrylcholinesterase (BuChE) in cholinergic signaling and
neurologic conditions, such as Alzheimer's disease (AD). The rationale for inhibiting …

[HTML][HTML] Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders

VK Ramanan, AJ Saykin - American journal of neurodegenerative …, 2013 - ncbi.nlm.nih.gov
The discovery of causative genetic mutations in affected family members has historically
dominated our understanding of neurodegenerative diseases such as Alzheimer's disease …

[HTML][HTML] Plasma proteins predict conversion to dementia from prodromal disease

A Hye, J Riddoch-Contreras, AL Baird, NJ Ashton… - Alzheimer's & …, 2014 - Elsevier
Background The study aimed to validate previously discovered plasma biomarkers
associated with AD, using a design based on imaging measures as surrogate for disease …

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

VK Ramanan, SL Risacher, K Nho, S Kim… - Molecular …, 2014 - nature.com
Deposition of amyloid-β (Aβ) in the cerebral cortex is thought to be a pivotal event in
Alzheimer's disease (AD) pathogenesis with a significant genetic contribution. Molecular …

Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals

F Song, A Poljak, J Crawford, NA Kochan, W Wen… - PloS one, 2012 - journals.plos.org
Objectives Apolipoproteins have recently been implicated in the etiology of Alzheimer's
disease (AD). In particular, Apolipoprotein J (ApoJ or clusterin) has been proposed as a …

Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis

J Kim, H Jiang, S Park, AEM Eltorai… - Journal of …, 2011 - Soc Neuroscience
The ε4 allele of the apolipoprotein E (APOE) gene is the strongest genetic risk factor for
Alzheimer's disease (AD). Evidence suggests that the effect of apoE isoforms on amyloid-β …

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

E Martínez-Morillo, O Hansson, Y Atagi, G Bu… - Acta …, 2014 - Springer
The apolipoprotein E (ApoE) ε4 allele is the strongest risk factor of sporadic Alzheimer's
disease (AD), however, the fluid concentrations of ApoE and its different isoforms (ApoE2 …

The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease

JE Morley, SA Farr, VB Kumar… - Current …, 2012 - ingentaconnect.com
The senescence accelerate mouse P8 (SAMP8) is an excellent model of early learning and
memory problems. A number of studies have shown that it has cholinergic deficits, oxidative …

New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease

I Zueva, J Dias, S Lushchekina, V Semenov… - …, 2019 - Elsevier
Profound synaptic dysfunction contributes to early loss of short-term memory in Alzheimer's
disease. This study was set up to analyze possible neuroprotective effects of two dual …